Week in Review
Clovis Oncology Inc. set terms for its proposed $130.2 million initial public offering.
Dynavax Technologies Corp. raised $60 million in a public stock offering.
Human Genome Sciences Inc. priced a public offering of $494.5 million in convertible senior notes.
Karyopharm Therapeutics Inc. completed a $10 million Series A2 financing.
Verastem Inc. filed to raise $50 million in an initial public offering.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST